Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact

Neurochemistry International

Volumn 32, Issue 5-6, 1998, Pages 449-456

  Andres, C ^a   Seidman, S ^b   Beeri, R ^b   Timberg, R ^b   Soreq, H ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOTONEURON; MOUSE; MUSCLE ATROPHY; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD MOTONEURON; SYNAPSE; TRANSGENE;

ACETYLCHOLINESTERASE; ANIMALS; AXONS; DENDRITES; DIAPHRAGM; HUMANS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MOTOR ENDPLATE; NEUROMUSCULAR JUNCTION; SPINAL CORD; SYNAPSES;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0032077169     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00121-6     Document Type: Article

References (40)

1. Aigner, L., Arber, S., Kapfhammer, J.P., Laux, C.S., Botteri, F., Brenner, H-R, Caroni, P., 1995. Over-expression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83, 269-278.
2. Andres, C., Beeri, R., Friedman, A., Lev-Lehman, E., Henis, S., Timberg, R., Shani, M., Soreq, H., 1997. ACHE transgenic mice display embryonic modulations in spinal cord CHAT and neurexin Iβ gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. U.S.A. 94, 8173-8178.
3. Anglister, L., 1991. Acetylcholinesterase from the motor terminal accumulates in the synaptic basal lamina of the myofiber. Cell Biol. 115, 755-764.
4. Anglister, L., Stiles, J.R., Salpeter, M.M., 1994. Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function. Neuron 12, 783-794.
5. Ben-Aziz-Aloya, R., Seidman, S., Timberg, R., Sternfeld, M., Zakut, H., Soreq, H., 1993. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. U.S.A. 90, 2471-2475.
6. Beeri, R., Andres, C., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M., Soreq, H., 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071.
7. Beeri, R., LeNovere, N., Mervis, R., Huberman, T., Grauer, E., Changeux, J.P., Soreq, H., 1997. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired ACHE-transgenic mice. J. Neurochem. 69, 2441-2451.
8. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
9. Burns, M.E., Augustine, G.J., 1995. Synaptic structure and function: Dynamic organization yields architectural precision. Cell 83, 187-194.
10. Carbonetto, S., Lindenbaum, M., 1995. The basement membrane at the neuromuscular junction: a synaptic mediatrix. Curr. Opin. Neurobiol. 5, 596-605.
11. Carraway, K.L., Burden, S.J., 1995. Neuregulins and their receptors. Curr. Opin. Neurobiol. 5, 606-612.
12. Coyle, J.T., Price, D.L., DeLong, M.R., 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1186-1189.
13. Crawford, T.O., Pardo, C.A., 1996. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Disease 3, 97-110.
14. Dechiarra, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S., Smith, C., DiStefano, P.S., Glass, D.J., Burden, S.J., Yancopoulos, G.D., 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85, 501-512.
15. Ellman, G.L., Courtney, D., Andres, V. Jr., Featherstone, R.M., 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
16. Engel, A.G., Santa, T., 1971. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann. N.Y. Acad. Sci., 183, 46-63.
17. Gautam, M., Noakes, P.G., Mudd, J., Nichol, M., Chu, G.C., Sanes, J.R., Merlie, J.P., 1995. Failure of post-synaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377, 232-236.
18. Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., Sanes, J.R., 1996. Defective neuromuscular synaptogenesis in agrin-deficient mice. Cell 85, 525-535.
19. Glass, D.J., Bowen, D.C., Stitt, T.N., Radziejewski, C., Bruno, J., Ryan, T.E., Gies, D.R., Shah, S., Mattsson, K., Burden, S.J., DiStefano, P.S., Valenzuela, D.M., DeChiara, T.M., Yancopoulos, G.D., 1996. Agrin acts via a MuSK receptor complex. Cell 85, 513-523.
20. Grinnell, A.D., 1995. Dynamics of nerve-muscle interaction in developing and mature neuromuscular junctions. Physiol. Rev. 75, 789-819.
21. Hall, Z.W., Sanes, J.R., 1993. Synaptic structure and development: the neuromuscular junction. Cell 10, 99-121.
22. Jo, S.A., Zhu, X., Marchionni, M.A., Burden, S.J., 1995. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature 373, 158-161.
23. Lambert, E.H., Elmqvist, D., 1971. Quantal components of end plate potentials in the myasthenic syndrome. Ann. N.Y. Acad. Sci. 183-199.
24. Layer P.G., Weikert, T., Alber, R., 1993. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of non-enzymatic mechanism. Cell Tissue Res. 273, 219-226.
25. Liao, J., Mortensen, V., Norgaard-Pedersen, B., Koch, C., Brodbeck, U., 1992. Monoclonal antibodies against brain acetylcholinesterase which recognize the subunit bearing the hydrophobic anchor. Eur. J. Biochem. 215, 333-340.
26. Lyons, P.R., Slater, C.R., 1991. Structure and function of the neuromuscular junction in young and adult mdx mice. J. Neurocytol 20, 969-981.
27. Massoulié, J., Pezzementi, L., Bon, S., Krejci, E., Vallette, F.M., 1993. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
28. Masu, Y., Wolf, E., Holtmann, B. Sendtner, M., Gottfried, B., Thoenen, H., 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27-32.
29. Noakes, P.G., Gautam, M., Mudd, J., Sanes, J.R., Merlie, J.P., 1995. Aberrant differentiation of neuromuscular junctions in mice lacking S-laminin/laminin β2. Nature 374, 258-262.
30. Plomp, J.J., Van-Kempen, G.T., De-Baets, M.B., Graus, Y.M., Kuks, J.B., Molenaar, P.C., 1995. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann. Neurol. 37, 627-636.
31. Robert, H., Brown, G. Jr., 1995. Amyotrophic lateral sclerosis: recent insight from genetics and transgenic mice. Cell 80, 687-692.
32. Schwarz, M., Loewenstein-Lichtenstein, Y., Glick, D., Liao, J., Norgaard-Pedersen, B., Soreq, H., 1995. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants. Molec. Brain Res. 31, 101-110.
33. Seidman, S., Sternfeld, M., Ben Aziz-Aloya, R., Timberg, R., Kaufer-Nachum, D., Soreq, H., 1995. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell Biol. 14, 459-473.
34. Shapira, M., Seidman, S., Sternfeld, M., Timberg, R., Kaufer, D., Patrick, J., Soreq, H., 1994. Transgenic engineering of neuromuscular junctions in Xenopus laevis embryos transiently over-expressing key cholinergic proteins. Proc. Natl. Acad. Sci. U.S.A. 91, 9072-9076.
35. Shillito, P., Vincent, A., Newsom-Davis, J., 1993. Congenital myasthenic syndromes. Neuromuscul. Disord. 3, 183-190.
36. Small, D.H., Reed, G., Whitefield, B., Nurcombe, V., 1995. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture. J. Neurosci. 15, 144-151.
37. Sternfeld, M., Ming, G.-l., Song, H.-j., Sela, K., Timberg, R., Poo, M.-m., Soreq, H., 1998. Acetylcholinesterase exerts a C-terminus specific, non-catalytic nerve growth promoting activity. J. Neurosci. 18, 1240-1249.
38. Sveistrup, H., Chan, R.Y., Jasmin, B.J., 1995. Chronic enhancement of neuromuscular activity increases acetylcholinesterase gene expression in skeletal muscle. Am. J. Physiol. 269, 856-862.
39. Wokke, L.H.J., Jennekens, F.G.I., van den Oord, C.J.M., Veldman, H., Smith, L.M.E., Leppink, G.J., 1990. Morphological changes in the human end plate with age. J. Neurol. Sci. 95, 291-310.
40. Zheng, J.Q., Felder, M., Connor, J.A., Poo, M-m., 1994. Turning of nerve growth cones induced by neurotransmitters. Nature 368, 140-144.